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Abstract 
 
Background and objectives: Unraveling the mechanisms of a number of enzyme 
models has allowed for the design of efficient chemical devices having the potential to be 
utilized as prodrug linkers that can be covalently attached to commonly used drugs which 
can chemically, and not enzymatically, be converted to release the active drug in a 
programmable manner. For instance, exploring the mechanism for a proton transfer in 
Kirby‘s N-alkylmaleamic acids (enzyme model) has led to the design of a number of 
prodrugs such as tranexamic acid, acyclovir, atenolol.  
Method: Based on density functional theory (DFT) calculations for the acid-catalyzed 
hydrolysis of several N-alkylmaleamic acid derivatives five 6-aminocapproic acid 
prodrugs were designed, aiming to provide a drug with potentially to have higher 
bioavailability than its parent drug. 
Result and discussion: DFT calculations at B3LYP/6-31G(d,p) for intramolecular 
proton transfer in 1-7 and prodrugs of 6-aminocapproic acid, ProD1-ProD5, 
demonstrated that the reaction rate is dependent on the strain energy difference between 
the intermediate and the reactant (Es INT-GM). This suggests that the reaction is governed 
by strain effect. Additionally, no correlation was found between the proton transfer 
efficiency and the distance between the two reactive centers (rGM) and the attack angle 
(α). 
Conclusion: Hence, the rate by which the prodrug releases the 6-aminocapproic acid 
drug can be determined according to the structural features of the promoiety (Kirby’s 
enzyme model). 
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Chapter one 
Introduction 
1.1 Prodrug 
The term prodrug was first introduced by Albert,  by using pharmacologically inactive 
chemical moiety which can be used to temporarily change  the physicochemical 
properties of a drug, in order to increase its usefulness and decrease its associated 
toxicity. The prodrug design usually implies a covalent link between a drug and a 
chemical entity [1]. Generally, in vivo, prodrugs can be enzymatically or chemically 
degraded to furnish the parent active drug which exerts its therapeutic effect. Ideally the 
aim of prodrug usage that have to be achieved, is the conversion of the prodrug to the 
parent drug and a non-toxic moiety, followed by the subsequent rapid elimination of the 
released linker group [2, 3]. 
Rationale of a Prodrug Design 
 The optimization of absorption, distribution, metabolism, and excretion properties 
(ADME) are the rationale behind the use of prodrugs. In addition, prodrug could be used 
to increase the selectivity of drugs for their intended target. Development of a prodrug 
with improved properties may also represent a life-cycle management opportunity. In 
order to increase the utility of biologically active compounds, the prodrug approach can 
be used as a very versatile strategy, because one can optimize any of the ADME 
properties of potential drug candidates [4]. Generally, some prodrugs contain a promoiety 
(linker) that is removed by an enzymatic or chemical reaction, while other prodrugs 
undergo molecular modification such as an oxidation or reduction reaction to release their 
active drugs. In some cases, the first promoiety linked to the parent drug molecule is 
attached to a second linker to have a double prodrug. These linkers are usually different 
each from other and are cleaved by different mechanisms. At other case, two biologically 
active drugs can be linked together in a single molecule called a codrug. In a codrug, each 
drug acts as a promoiety for the other [5]. 
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The Prodrug Design Can Be Utilized In The Following 
(i) Improving the solubility and consequently bioavailability of the active drug; 
more than 30% of drug discovery compounds have poor aqueous solubility. 
The rate-limiting step to absorption  may be the dissolution of the drug 
molecule from the dosage form [6]. In order to increase the aqueous solubility 
of the parent drug molecules, the prodrug approach can be used via attached 
ionizable or polar neutral functions, such as phosphates, amino acids, or sugar 
moieties to the active drug. So, the dissolution rate are will be improved  [7]. 
These prodrugs can be used not only to enhance oral bioavailability but also to 
prepare parenteral or injectable drug delivery. 
(ii)  Increasing permeability and absorption; the efficacy of the drug is affected by 
membrane permeability [3]. Unfacilitated and largely nonspecific passive 
transport mechanisms are the most common absorption routes in oral drug 
delivery. The hydrocarbon moiety modification, can be used to enhance the 
lipophilicity of poorly permeable drugs. In such cases, the prodrug strategy 
can be an extremely valuable option. Improvement of the lipophilicity has 
been the most widely investigated and successful field in prodrug research. 
This improvement can be achieved by masking polar ionized or nonionized 
functional groups. So, oral or topical absorption  is expected to be enhanced 
[8]. 
(iii)  Distribution profile modification; before the drug reaches its physiological 
target and exerts the desired effect. Thus, several pharmaceutical and 
pharmacokinetic barriers have to be bypassed. 
(iv)  Fast metabolism and excretion prevention; the total amount of active drug 
that reaches the systemic circulation and consequently its target, may be 
greatly reduced by the first-pass effect in the gastrointestinal tract and liver. 
Sublingual or buccal administration or controlled release formulations could 
be used to overcome this problem. The prodrug strategy can also be used to 
prevent fast metabolic drug degradation . This is usually done by masking the 
metabolically labile but pharmacologically essential functional group(s) of the 
drug. 
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(v)  Reduction of the toxicity; the structure or function of cells, tissues, and 
organs which can be detrimental to the organism can be changed by adverse 
drug reactions. Targeting drugs to desired cells and tissues via site-selective 
drug delivery is often used to reduce the toxicity; also in sometimes this can 
be accomplished by altering one or more of the ADME barriers. A successful 
site-selective prodrug must be precisely transported to the site of action, where 
it should be selectively and quantitatively transformed into the active drug, 
which is retained in the target tissue to produce its therapeutic effect [9]. The 
opportunities for selective drug delivery and targeting may be diminished by 
the ubiquitous distribution of most of the endogenous enzymes that are 
responsible for prodrugs bioactivation. Therefore, antibody-directed enzyme 
prodrug therapy or genes that encode prodrug activating enzymes are used to 
deliver exogenous enzymes selectively. This approach is particularly used 
with highly toxic compounds in order to reduce the toxicity of the drugs at 
other sites in the body such as anticancer drugs [10, 11]. 
The prodrug approach strategy is facing two major challenges 
 (1) Hydrolysis of prodrugs by esterases; prodrugs undergoing in vivo cleavage to the 
active drug by catalysis of hydrolases such as peptidases, phosphatases, and 
carboxylesterases. The hydrolysis is considered as the aim of  most common prodrugs 
approaches [8]. The main challenge with prodrugs susceptible to esterase hydrolysis is 
the less than complete absorption which observed with several hydrolase-activated 
prodrugs of penicillins, cephalosporins, and angiotensin converting enzyme inhibitors. 
Due to their premature hydrolysis during the absorption process in the enterocytes of the 
gastrointestinal tract, these prodrugs typically have bioavailabilities around 50% [8]. The 
active drug upon hydrolysis is released inside the enterocytes, in most cases it is more 
polar and less permeable than the prodrug and is more likely to be effluxes by passive 
and carrier-mediated processes back into the lumen than to proceed into blood, therefore 
limiting oral bioavailability.  
(2) Bioactivation of the prodrug by cytochrome P450 enzymes.  The variability in 
prodrug activation and thus to the efficacy and safety of drugs using P450s bioactivation 
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pathwayis due to genetic polymorphisms of a prodrug activating P450s [12]. Because 
there are many intrinsic and extrinsic factors that can influence the process, 
bioconversion of prodrugs is perhaps the most vulnerable link in the chain. For example, 
genetic polymorphisms, age-related physiological changes, or drug interactions, which 
leads to adverse pharmacokinetic, pharmacodynamics, and clinical effects, may lead to 
decrease or increase in the activity of many prodrug activating enzymes. Besides that, 
there are wide interspecies variations in both the expression and function of the major 
enzyme systems activating prodrugs, and these can pose challenges in the preclinical 
optimization phase [13]. 
Nonetheless, searching for an entirely new therapeutically active agent with suitable 
ADMET properties is more difficult and complicated than developing a prodrug. 
Chemical and enzymatic stability, solubility, low clearance by the liver or kidney, 
permeation across biological membranes, potency, and safety, all these specific 
properties have to be found in an ideal drug candidate. So, prodrug development can still 
be a more feasible and faster strategy  [14].  
In the prodrug approach, the conversion of a prodrug to the parent drug at the target site 
is crucial, to be successful approach. Generally, metabolisms by enzymes that are 
distributed throughout the body are involved in the activation. These prodrugs have a 
major problem, which is the difficulty in predicting their bioconversion rates, and thus 
their pharmacological or toxicological effects. In addition, the rate of hydrolysis is not 
always predictable, and various factors such as age, health conditions and gender  can 
affect  the bioconversion [15]. 
In order to minimize or eliminate the undesirable drug physicochemical properties while 
maintaining the desirable pharmacological activity, there are two major prodrug design 
approaches that are considered as widely used among all other approaches [16]. The first 
approach is the targeted drug design approach, by which prodrugs can be designed to 
target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-
substrate specificity in order to overcome various unwanted drug properties. 
Considerable knowledge of particular enzymes or carriers, including their molecular and 
functional characteristics are required for this type of "targeted-prodrug"  [17]. Antibody-
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directed enzyme prodrug therapy (ADEPT) or antibody-directed catalysis is an example 
for such approach. In this strategy, antigens expressed on tumors cells are utilized to 
target enzymes to the tumor site. At the beginning in such approach, an enzyme-antibody 
conjugate is administered and given sufficient time to interact with tumor cells and to be 
eliminated from the circulation. Subsequently, a prodrug is given and selectively 
activated extracellular at the tumor site [18]. 
 Gene-directed enzyme prodrug therapy (GDEPT) and virus-directed enzyme prodrug 
therapy (VDEPT) are alternative approaches designed to overcome the limitations of 
(ADEPT) [19]. In these approaches, prodrug administration follows genes encoding 
prodrug-activating enzymes which are targeted to tumor cells. In GDEPT, for gene 
targeting  non-viral vectors that contain gene-delivery agents, such as peptides, cationic 
lipids or naked DNA, are used [20]. In VDEPT, viral vectors are used for gene targeting, 
the most commonly used viruses are retroviruses and adenoviruses. For both GDEPT and 
VDEPT, the vector has to be taken up by the target cells, and the enzyme must be stably 
expressed in tumor cells. This process is called transduction [21]. Insufficient 
transduction of tumor cells in vivo has limited the effectiveness of GDEPT and VDEPT.  
The chemical design approach  is the second approach, by which the drug is linked to 
inactive organic moiety which upon exposure to physiological environment releases the 
parent drug and a non-toxic linker which should be eliminated without affecting the 
clinical profile. 
There are two main classes of prodrugs: (1) carrier linked prodrugs, and (2) bioprecursor 
prodrugs. In the carrier-linked prodrugs, the active molecule (the drug) is temporary 
linked to a carrier (also known as a promoiety) through a bio-reversible covalent linkage. 
When the carrier-linked prodrug is exposed to physiological environment, it undergoes 
biotransformation, releasing the parent drug and the carrier. Ideally, the carrier should be 
non-immunogenic, easy to synthesize at a low cost, stable under the conditions of 
prodrug administration, and undergo biodegradation to inactive metabolites [22].  
Based on the site of conversion into the pharmacologically active agent, the prodrugs can 
be additionally classified into two groups: 
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 • Type I – metabolized intracellularly. Type IA prodrugs (e.g., acyclovir, 
cyclophosphamide, 5-fluorouracil, L-DOPA, zidovudine) are metabolized at the cellular 
targets of their therapeutic actions. Type IB prodrugs (e.g., carbamazepine, captopril, 
molsidomine, primidone) are converted to parent drugs by metabolic tissues, namely by 
the liver. 
• Type II – metabolized extracellularly. Type IIA – in the milieu of the gastrointestinal 
fluid (e.g., loperamide oxide, sulfsalazine). Type IIB – within the circulatory system 
and/or other extracellular fluid compartments (e.g., aspirin, bambuterol, fosphenytoin). 
Type IIC – near or inside therapeutic target/cells (ADEPT, GDEPT) [22]. 
Currently, 5–7% of the approved drugs worldwide can be classified as prodrugs, and 
approximately 15% of all new drugs approved in 2001 and 2002 were prodrugs.  
 
1.2 Computational Methods Background 
Few decades ago, computational methods for calculating molecular properties of ground 
and transition states has been used by organic, bioorganic and medicinal chemists, in 
order to solve chemical problems. These computational methods use principles 
of computer science, for calculating the structures, physical and chemical properties 
of molecules. Theoretical results emerged from these methods, incorporated into 
efficient computer programs.  
Today, for predicting structure-energy calculations for drugs and prodrugs alike, quantum 
mechanics (QM) such as ab initio, semi-empirical, density functional theory (DFT), and 
molecular mechanics (MM) are commonly and increasingly being used,  and broadly 
accepted as precise tools [23]. 
Both static and dynamic situations can be handled by the above mentioned computational 
methods. In all cases when the studied system‘s size increase, the computer time, 
memory and disk space increase drastically. [24] 
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1.2.1 Ab initio methods 
Three decades ago, ab initio quantum chemistry has become important tool in the study 
of atoms, molecules and, increasingly, in modeling complex systems such as those 
arising in biology and materials science. The computational solution of the electronic 
Schrodinger equation is the underlying core technology. In this equation, by means of a 
well-defined, automated approximation, the positions of a collection of atomic nuclei, 
and the total number of electrons in the system can be determined, it is also can be used 
to calculate the electronic energy, electron density, and other properties. For systems 
containing tens, or even hundreds, of atoms, the ability to obtain “good-enough” 
solutions to the electronic Schrodinger equation has revolutionized the ability of 
theoretical chemistry to address essential problems in a wide range of disciplines; the 
Nobel Prize awarded to John Pople and Walter Kohn in 1998 is a reflection of this 
observation [25]. 
 Ab initio methods are based entirely on theory from first principles.  They are generally 
useful only for small systems. The ab initio molecular orbital methods, such as HF, G1, 
G2, G2MP2, MP2, MP3 and MP4 are based on rigorous use of the Schrodinger equation 
with a number of approximations. When all approximations are sufficiently small in 
magnitude and when the finite set of basis functions tends toward the limit of a complete 
set. Ab initio electronic structure methods have the advantage that they can be made to 
converge to the exact solution.  The convergence is usually not monotonic, and 
sometimes the smallest calculation gives the best result for some properties. But The 
disadvantage of ab initio methods is their enormous computational cost, they take a 
significant amount of computer time, memory, and disk space  [26]. 
Schrodinger equation: is a fundamental equation of physics for describing quantum 
mechanical behavior. It is also often called the Schrödinger wave equation, and it is a 
partial differential equation that describes how the wave-function of a physical system 
evolves over time.  
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H is the Hamiltonian Operator of the system (a set of operations which enables one to 
calculate its energy),  is the Wave-function which describes the positions and motions 
of all the particles (nuclei and electrons) of the system, and E is the energy. 
To solve this equation, one needs to make a few approximations. The first is called the 
Born-Oppenheimer approximation, and consists in assuming that the nuclei do not move 
on the timescale of electron motion. Therefore one can find wave-functions and energies 
for the electrons at a given, "frozen", nuclear configuration. 
1.2.2. Semi-empirical methods 
 Semi-empirical method make many approximations, and obtain some parameters from 
empirical data, thus they are less accurate methods. The semi-empirical quantum methods 
depend on the Hartree–Fock formalism and they are very important in computational 
chemistry for treating large molecules. Semi-empirical calculations are much faster than 
their ab initio counterparts. If the molecule being computed is not close enough to the 
molecules in the data base used to parameterize the method, their results can be 
inaccurate. The most used semi-empirical methods are MINDO, MNDO, MINDO/3, 
AM1, PM3 and SAM1 [27]. 
Despite their limitations, semi-empirical methods allow a study of systems that are out of 
reach of more accurate methods, so they  are often used in computational chemistry. For 
example, molecules consisting of thousands of atoms could be studied by modern semi-
empirical programs, while ab initio calculations that obtain similar thermochemical 
accuracy are feasible on molecules consisting of less than 50-70 atoms. Semi empirical 
calculations may be useful in several situations, such as: 
1.  Computational modeling of structure-activity relationships to gain insight about 
reactivity or property trends for a group of similar compounds. 
2.  Development and testing of new methodologies and algorithms, for example 
development of hybrid quantum mechanics / molecular mechanics (QM/MM) methods 
for modeling of biochemical processes. 
 10 
3. Checking for gross errors in experimental thermochemical (e.g. heat of formation) 
data. 
4. In many applications where qualitative insight about electronic structure and properties 
is sufficient. 
In general, the result of semi-empirical can be trusted only in situations when they are 
known to work well (e.g. systems similar to molecules in the parameterization set) and 
strong caution should be taken in cases where semi-empirical methods are known to fail 
(e.g. prediction of activation barriers).  
1.2.3 Density functional theory 
The density functional theory (DFT) is another commonly used quantum mechanical 
modeling method in physics and chemistry. It is used to investigate the electronic 
structure (principally the ground state) of many-body systems. With this theory, 
functionals can be used to determine the properties of many-electron systems. Hence, the 
name density functional theory comes from the use of functionals of the electron density.  
Unlike the wave-function, which is not a physical reality but a mathematical construct, 
electron density is a physical characteristic of all molecules. So, DFT is among the most 
popular and versatile methods available in condensed-matter physics, computational 
physics, and computational chemistry. The DFT method is used to calculate structures 
and energies for medium-sized systems (30–60 atoms) of biological and pharmaceutical 
interest and is not restricted to the second row of the periodic table [28]. 
A functional is defined as a function of a function, and the energy of the molecule is a 
functional of the electron density. The electron density is a function with three variables– 
x-, y-, and z-position of the electrons. Unlike the wave-function which becomes 
significantly more complicated as the number of electrons increases, the determination of 
the electron density is independent of the number of electrons. 
DFT is widely used computational method, and can be applied to most systems. Like all 
computational methods, DFT methods are more useful for some types of calculations 
than others. DFT methods, unlike ab initio methods, can be used for calculations 
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involving metals. Hybrid methods, such as B3LYP, are often the method of choice for  
reaction calculations. Some DFT methods are specifically designed for specific 
applications, such as the MPW1K hybrid method, designed for determination of kinetics 
problems. 
 
The most significant advantage to DFT methods is a significant increase in computational 
accuracy without the additional increase in computing time. DFT methods such as 
B3LYP/6-31G(d) are oftentimes considered to be a standard model chemistry for many 
applications [29]. 
 
The use of DFT method  is significantly increasing but some difficulties still encountered 
when describing intermolecular interactions, especially van der Waals 
forces (dispersion); charge transfer excitations; transition states and some other strongly 
correlated systems. Incomplete treatment of dispersion can adversely affect the DFT 
degree of accuracy in the treatment of systems which are dominated by dispersion. Also, 
there is a challenge in determining the most appropriate method for a particular 
application. The practitioner should, prior to choosing a DFT method, consult the 
literature to determine the suitability of that choice for that particular problem or 
application. In general practice (including educational environments), the B3LYP/6-
31g(d) model chemistry is considered by most to be a good general-purpose choice [28]. 
 
1.2.4 Molecular mechanics 
   
 Molecular mechanics is a mathematical approach used for the computation of structures, 
energy, dipole moment, and many other physical properties. Many diverse biological and 
chemical systems are widely calculated by this method such as proteins, large crystal 
structures, and relatively large solvated systems. However, determination of parameters 
such as the large number of unique torsion angles present in structurally diverse 
molecules make a limitation for this method [30]. 
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Molecular mechanics can also be used to supply the potential energy for molecular 
dynamics computations for large molecules. But, they are inappropriate for bond-
breaking reactions. 
In order to investigate functional mechanisms of biological macromolecules based on 
their 3D and electronic structures, Ab initio methods have been utilized. The size of the 
system, which ab initio calculations can handle, is relatively small despite the large sizes 
of bio-macromolecules surrounding solvent water molecules. Accordingly, ab initio 
calculations can be used in isolated models of areas of proteins such as active sites. 
However, the regulation of electronic structures and geometries of the regions of interest 
have been affected by the disregarded proteins and solvent surrounding the catalytic 
centers. 
Quantum mechanics/molecular mechanics (QM/MM) calculations are utilized to 
overcome the above discrepancies, in this type of calculations  the system is divided into 
QM and MM regions, where QM regions correspond to active sites to be investigated and 
are described quantum mechanically. MM regions which are described molecular 
mechanically are correspond to the remainder of the system. Warshel and Levitt were the 
pioneer in this work of the QM/MM method [31], and since then, there has been much 
progress on the development of a QM/MM algorithm and applications to biological 
systems [32]. 
 
1.3  6-Aminocaproic acid 
 
 6-Aminohexanoic acid (Figure 1) is a synthetic lysine analog that suppresses fibrinolytic 
activity by fitting into plasminogen´s lysine-binding site and preventing the binding of 
plasminogen to fibrin [33]. 
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                                      Figure 1: Chemical structure of 6-aminocaproic acid  
                     
Other anti-fibrinolytic drugs that are available are aprotinin, and tranexamic acid, which 
used intraoperatively, postoperatively, and during extracorporeal membrane oxygenation 
(ECMO) to reduce bleeding and minimize the need for exogenous blood products. 
However, because of risk of renal failure, cardiac failure, stroke, or encephalopathy that 
is associated with the use of aprotinin, the latter was removed from the market. Hence, 6-
aminocaproic acid and tranexamic acid are potentially safer alternatives. In the UK, 
tranexamic acid, a tissue plasminogen and plasmin inhibitor, is most commonly used, 
with evidence for benefit in cardiac, orthopaedic, urological, gynaecological, and 
obstetric surgery. In the USA, 6-aminocaproic acid, which also inhibits plasmin, is 
commonly used [34]. 
 
 
Figure 2: chemical structure of tranexamic acid 
 
Studies on this drug have showed a clinical benefit in decreasing mortality and morbidity 
in many traumatic cases, and in different types of surgery, like coronary artery bypass 
grafting in which the administration of 6-aminocaproic acid resulted in a significant 
decrease in blood loss and blood transfusion requirements [35]. Also, the administration 
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of this drug can reduce blood loss and consequently transfusion and transfusion-related 
risk in patient who undergoes hip replacement [36] . 
As well as, it can reduce the incidence of secondary hemorrhage following traumatic 
hyphema [37]. It plays an important role in dental extraction in patients with hemophilia 
[38], and in control hemorrhage in patients with amegakaryocytic thrombocytic 
thrombocytopenia [39] . 
 In adults, oral absorption appears to be a zero-order process. Renal excretion is the 
primary route of elimination, whether aminocaproic acid is administered orally or 
intravenously. Sixty-five percent of the dose is recovered in the urine as unchanged drug 
and 11% of the dose appears as the metabolite adipic acid. The terminal elimination half-
life is approximately 2 hours. 
 
 
1.4 Research problem 
 
The bioavailability of 6-aminocaproic acid is only 24%. This low value is attributed to 
the amino acid nature of the drug. At physiological pH, 6-aminocaproic acid exists 
mainly in the ionized form; this ionization decreases the ability of 6-aminocaproic acid to 
be transferred to the systemic blood circulation. This limited permeation results in poor 
bioavailability of the anti-bleeding drug [40]. 
Thus, using the prodrug approach to increase 6-aminocaproic acid bioavailability can be 
utilized. This can be achieved by making a covalent linkage between 6-aminocaproic acid 
and a non-toxic promoiety that increases the lipophilicity of 6-aminocaproic acid.  
The proposed prodrugs were designed such that the prodrug will be chemically 
intraconverted to 6-aminocaproic acid and a non-toxic moiety in a rate which is only 
dependent on the structural features of the inactive linker. 
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1.5 Thesis objective 
 
1.5.1 General objective 
To design 5 prodrugs of 6- aminocaproic acid which have better bioavailability than 6-
aminocaproic acid, using a variety of different molecular orbital and molecular 
mechanics methods and correlations between experimental and calculated reactions rates. 
 
1.5.2 Specific objective 
 
►Calculations of Kirby’s enzyme model mechanism for the design of 6-aminocaproic 
acid prodrugs which have the following properties: 
1- Converted to 6-aminocaproic acid in a controlled manner. 
2- The linker attached to the drug moiety and the whole 6-aminocaproic acid 
prodrug moiety should be non-toxic and safe. 
3- Enhanced bioavailability compared to the naked 6-aminocaproic acid.   
 
 
1.6 Research questions  
 
  Would the DFT and ab inito methods be capable of predicting reaction rates 
similar to that obtained by Kirby? 
 Would the DFT calculations be good methods for a design of 6-aminocaproic 
acid prodrugs that have the potential to increase the bioavailability of the active 
drug and be cleaved in physiological environments to furnish the active drug and 
a non-toxic moiety? 
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Chapter Two 
Literature Review 
 
2.1 Inter- and Intramolecular Chemical Processes 
There are two kinds of forces, or attractions that operate in molecule 
intramolecular and intermolecular forces. Intermolecular forces: The forces holding 
molecules together and play important roles in determining the properties of substances. 
Intermolecular forces are particularly important in terms of how molecules interact and 
form biological organisms or even life. 
 Bulk properties such as the melting points of solids and the boiling points of liquids are 
determined by intermolecular forces. When the molecules in liquids have enough thermal 
energy to overcome the intermolecular attractive forces that hold them together, the 
boiling happened, thereby forming bubbles of vapor within the liquid. Similarly, solids 
melt when the molecules acquire enough thermal energy to overcome the intermolecular 
forces that hold them into place in the solid. 
Intermolecular forces arise from the interaction between positively and negatively 
charged species, so, they are electrostatic in nature. Like covalent and ionic bonds, 
intermolecular interactions are the sum of both attractive and repulsive components [41].  
There are three major types of intermolecular interactions: 
1- Dipole–dipole interactions:  arise from the electrostatic interactions of the positive 
and negative parts of molecules with permanent dipole moments; their strength is 
proportional to the magnitude of the dipole moment and to 1/r
6
, where r is the 
distance between dipoles. 
2- London dispersion forces:  the formation of instantaneous dipole moments in 
polar or nonpolar molecules as a result of short-lived fluctuations of electron 
charge distribution is the main cause for London force formation. As a result 
temporary formation of an induced dipole in adjacent molecules occurred. The 
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outer electrons of larger atom are less tightly bound and are therefore more easily 
perturbed, so, larger atoms tend to be more polarizable than smaller ones. 
3- Hydrogen bonds: are especially strong dipole–dipole interactions between 
molecules that have hydrogen bonded to a highly electronegative atom, such as O, 
N, or F. The resulting partially positively charged H atom on one molecule 
(the hydrogen bond donor) can interact strongly with a lone pair of electrons of a 
partially negatively charged O, N, or F atom on adjacent molecules (the hydrogen 
bond acceptor).  
Intramolecular forces: is any force that holds the atoms together making up a molecule or 
compound, they contain all types of chemical bond and are stronger than intermolecular 
forces [42]. 
2.2 Intramolecular Processes Used for the Design of Potential Prodrugs 
Many organic chemists and biochemists have been inspired in the striking efficiency of 
enzyme catalysis, to explore enzyme mechanisms by investigating particular 
intramolecular processes such as enzyme models which proceed faster than their 
intermolecular counterparts. This research brings about the important question of whether 
enzyme models have the ability to replace natural enzymes in the conversion of prodrugs 
to their parent drugs. 
 Enzymes are mandatory for the interconversion of many prodrugs to their active parent 
drugs. In this bioconversion of the prodrugs, there are important enzymes involved which 
include amides, such as, trypsin, chymotrypsin, elastase, carboxypeptidase, and 
aminopeptidase, and esters, such as paraoxonase, carboxylesterase, cetylcholinesterase 
and cholinesterase. Most of these enzymes are hydrolytic enzymes, however, non-
hydrolytic ones, including all cytochrome P450 enzymes, are also capable of catalyzing 
the bioconversion of ester and amide-based prodrugs.  
In intramolecular processes (enzyme models) approach, the intraconversion of a prodrug 
to its active parent drug does not require enzyme catalysis.  The release rate of the active 
drug is determined only by the factors playing dominant role in the rate limiting step of 
the intraconversion process. All disadvantages associated with prodrug interconversion 
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by enzymes have the potential to be eliminated by using this approach. As discussed 
before, prodrug bioconversion is perhaps the most vulnerable link in the chain, since 
many intrinsic and extrinsic factors can affect the interconversion process. 
2.3 Computationally Designed Prodrugs Based On Enzyme Models 
Over the past sixty years, many pioneering studies have been vastly contributed in 
understanding how enzymes catalyze biochemical transformations. Today, the scientific 
community consensus  that enzyme catalysis is based on the combination effects between 
the catalysis by functional groups and the ability to reroute intermolecular reactions 
through alternative pathways by which substrates can bind to pre organized active sites.  
In general, enzymatic reaction rates are 10
10
 to 10
18
 fold more than their non-enzymatic 
bimolecular counterparts. The substrate binding within the confines of the enzyme active 
site is the main cause to the tremendous rate acceleration which manifested by enzyme. 
The main driving force and contributor to catalysis is the binding energy of the resulting 
enzyme substrate complex. It is assumed that this binding energy is used to overcome the 
physical and thermodynamic factors that make barriers to the reaction (free energy) in all 
bio-transformations catalyzed by enzymes [43-46]. 
The chemists are fascinated by the high rates of intramolecular reactions, because they 
remind them of the efficiency of enzyme catalysis and it is broadly believed that a 
common source is, at least for a significant part, responsible for both enthalpic and 
entropic effects. A number of chemists and biochemists have been prompted by the 
similarity between intramolecularity and enzymes in order  to design chemical models 
based on intramolecular reactions consisting of two reacting centers to understand the 
mode and the mechanism by which enzymes exert their high catalytic activities [47-49] . 
In the past five decades proposals have been made from attempts to interpret changes in 
reactivity versus structural variations in intramolecular systems. Among these proposals: 
 (i) Koshland   orbital steering   that suggests a rapid intramolecularity comes from a 
severe angular dependence of organic reactions, such as in the lactonization of rigid 
hydroxy acids [50] 
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 (ii)   proximity in intramolecular processes (near attack conformation) model as proposed 
by Bruice and demonstrated in the lactonization of di-carboxylic acids semi-esters [51, 
52] 
 (iii)   stereopopulation control  based on the concept of freezing a molecule into a 
productive rotamer as advocated by Cohen [53-55] 
 (iv) Menger‘s  spatiotemporal hypothesis  which postulates that the rate of reaction 
between two reactive centers is proportional to the time that the two centers reside within 
a critical distance [56-58] 
 (v) Kirby‘s proton transfer models on the acid-catalyzed hydrolysis of acetals and N-
alkylmaleamic acids which demonstrated the importance of hydrogen bonding formation 
in the products and transition states leading to them [49, 59, 60]. 
Investigation on intramolecularity have played essential role in elucidating the chemistry 
of functional groups involved in enzyme catalysis as well as in unraveling the 
mechanisms proposed for particular processes. Thus, it is highly believed that these 
investigations have the potential to provide an adequate understanding of how efficiency 
depends on structure in intramolecular catalysis which in turns could shed light on related 
problems in enzyme catalysis. In addition, understanding these intramolecular processes 
can provide a basis for a design of prodrugs that have the ability to release their active 
parent drugs in predicted manner. 
At Intramolecular reactions the functional groups bring together on the same molecule, 
to model what goes on when an enzyme brings together the same functional groups in its 
active site [61]. The distance between the two reacting centers determine the nature of the 
reaction (intermolecular or Intramolecular). Ab initio calculations done by Karaman  and 
Menger demonstrated that when the distance between the two reacting centers is about 
2.4A , the reaction is intramolecular, whereas when the distance is 3A  and more, the 
reaction prefers the intermolecular process [62]. 
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Karaman’s group advocate The mechanisms of some intramolecular processes to 
understand enzyme catalysis (enzyme models) in order to design novel prodrug linkers 
[63]. Among the studied intramolecular processes: 
o Acid-catalyzed lactonization of hydroxy-acids as researched by Cohen [64] 
and Menger[65]. 
o SN2-based ring closing reactions as studied by Brown, Bruice, and 
Mandolin [66]. 
o Proton transfer between two oxygens in Kirby’s acetals [67, 68], and 
proton transfer between nitrogen and oxygen in Kirby’s enzyme models 
[67, 68] and proton transfer from oxygen to carbon in some of Kirby’s enol 
ethers[69]. 
The  recent studies of Karaman group on intramolecularity have demonstrated that there 
is a necessity to further explore the reaction mechanisms in order to determine the factors 
affecting the reaction rate such as (1) The driving force for enhancements in rate for 
intramolecular processes are both entropy and enthalpy effects. In the cases by which 
enthalpic effects were predominant such as ring-cyclization and proton transfer reactions 
proximity or/and steric effects were the driving force for rate accelerations. (2) The 
distance between the two reactive centers determine the nature of the reaction being 
intermolecular or intramolecular. (3) In SN2-based ring-closing reactions leading to 
three-, four- and five-membered rings the gem-dialkyl effect is more dominant in 
processes involving the formation of an unstrained five-membered ring, and the need for 
directional flexibility decreases as the size of the ring being formed increases. (4) 
Accelerations in the rate for intramolecular reactions are a result of both entropy and 
enthalpy effects, and (5) in Kirby‘s acetal systems, an efficient proton transfer between 
two oxygens and between nitrogen and oxygen were affordable when strong hydrogen 
bonds are developed in the products and the corresponding transition states leading to 
them [63, 65, 66]. Unraveling the reaction mechanism would allow for better design of an 
efﬁcient chemical device to be utilized as a prodrug linker that can be covalently linked 
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to a drug which can chemically, but not enzymatically, be cleaved to release the active 
drug in a programmable manner. 
 
2.3 Kirby’s Enzyme Model Based on the Acid Catalyzed Hydrolysis of N-
Alkylmaleamic Acids 
Proton transfer reactions are the most common processes catalyzed by enzymes. 
Scientists have encouraged exploiting intramolecularity in modeling enzyme catalysis 
due to the fact that reactions of an enzyme active site and substrate are between 
functional groups held in a close proximity. Both, enzymes and intramolecularity are 
similar in that the reacting centers are held together, noncovalently with the enzymes, and 
covalently with the intramolecular process. The tremendous high efficiency of enzymes 
catalysis depends on a combination of some factors that most of them have been 
recognized but none of them was fully understood. Although the devoted research to the 
chemistry of enzyme catalysis is growing rapidly a number of several factors remain to 
be studied [70, 71]. 
The acid-catalyzed hydrolysis of 1-7 maleamic acid (Figure 3) was kinetically 
investigated by Kirby et al. The study demonstrated that the cleavage of  amide bond is 
due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the 
tetrahedral intermediate breakdown is the  rate-limiting step (scheme 1) [72]. In 1996, the 
reaction was computationally investigated by Katagi using AM1 semi-empirical 
calculations. In contrast to what was suggested by Kirby, Katagi’s study demonstrated 
that the rate- limiting step is the formation of the tetrahedral intermediate and not its 
dissociation [73]. Later on, Kluger and Chin have experimentally researched the 
mechanism of the intramolecular hydrolysis process utilizing several N-alkylmaleamic 
acids derived from aliphatic amines with a wide range of basicity [74]. The study 
findings demonstrated that the identity of the rate-limiting step is function of both the 
basicity of the leaving group and the solution acidity [75].   
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                Figure (3): Acid-catalyzed hydrolysis of N-alkylmaleamic acids 1-7 
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Scheme 1: Proposed mechanism for the acid-catalyzed hydrolysis of N-alkylmaleamic 
acids. 
 
Moreover, the calculations demonstrate that the rate-limiting step is dependent on the 
reaction medium. When the calculations were run in the gas phase the rate-limiting step 
was the tetrahedral intermediate formation, whereas when the calculations were 
conducted in the presence of a cluster of water the rate-limiting step is the dissociation of 
the tetrahedral intermediate. When the leaving group (methylamine) in 1-7 was replaced 
with a group having a low pKa value the hydrolysis in water was the formation of the 
tetrahedral intermediate which is the rate-limiting step . 
 In addition, the calculations revealed that the efficiency of the intramolecular acid-
catalyzed hydrolysis by the carboxyl group is remarkably sensitive to the pattern of 
substitution on the carbon–carbon double bond; 1) difference between strain energy 
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between intermediate and product and strain energy between intermediate and reactant; 
2) distance between hydroxyl oxygen of the carboxylic group and amide carbonyl carbon 
and 3) the attack angle. The rate of hydrolysis was found to be linearly correlated with 
the strain energy of the tetrahedral intermediate or the product. Systems having strained 
tetrahedral intermediates or products experience low rates and vice versa [49, 76-78]. 
In order to design novel prodrugs , Kirby’s enzyme model have been utilized [72] , a 
mechanistic study using DFT calculation methods at B3LYP/6-31G (d,p), B3LYP/311+G 
(d,p) levels and hybrid GGA (MPW1k) on an intramolecular acid catalyzed hydrolysis of 
maleamic (4-amino-4-oxo-2- butenoic) acids (Kirby’s N-alkylmaleamic acids) 1-7 was 
conducted. The calculations confirmed that the reaction involves three steps: (1) proton 
transfer from the carboxylic group to the adjacent amide carbonyl oxygen, (2) 
nucleophilic attack of the carboxylate anion onto the protonated carbonyl carbon; and (3) 
dissociation of the tetrahedral intermediate to provide products (scheme 1). 
Based on the calculation results of Kirby`s model (proton transfer in N-alkylmaleamic 
acids) we propose five 6-aminocaproic acid prodrugs using 5 linkers (Figure 4) 
 
 
                     Figure 4: anhydride linkers used in the five 6 aminocaproic acid prodrug.  
 As shown in (equation 2), 6-aminocaproic acid ProD1-ProD5 have a carboxylic group 
(hydrophilic moiety) and a lipophilic moiety (the rest of the prodrug), where the 
combination of both moieties secures a relatively modified HLB. 
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In most of the  physiologic environments (pH 1- 8.0) 6-aminocaproic acid will exist 
primary in the ionized forms (equation 1) while its prodrugs, 6-aminocaproic acid 
ProD1-ProD5, will equilibrate between the ionic and the free acid forms (equation 2) 
especially in a physiological environment of  pH 5.5-6.8 (intestine). Thus, it is expected 
that 6-aminocaproic acid ProD1- ProD5 may have a better bioavailability than the parent 
drug due to neutralizing the ionized amine group which results in absorption 
improvement. In addition, these prodrugs may be used in different dosage forms (i.e. 
enteric coated tablets, topical use and etc.) because of their potential solubility in organic 
and aqueous media due to the ability of the carboxylic group to be converted to the 
corresponding carboxylate anion in a physiological pH of around 6.0. 
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Chapter Three 
Computational (Design) section 
 
Calculation Programs and method 
3.1 Calculation Programs 
The following calculation programs were used in the prodrugs design: 
1-ArgusLab 
2-Guassian 2009 
3-Molden 
 
3.1.1 Argus lab 
Argus Lab is a very versatile freeware, This software was originally intended to perform 
only semi-empirical quantum mechanical (QM) calculations on small molecules, but has 
now grown to be used for several types of computational chemistry experiments as well 
as molecular-docking experiments which is useful for biological chemists.  
 Argus Lab can be used easily to do molecular mechanics (MM) (UFF/Amber force 
fields) and QM semi-empirical (MINDO, AMI, PM3) , it can be used also, for many 
calculations such as evaluating single-point energies for fixed geometry, geometry 
optimization in the ground state, and more importantly obtain UV-VIS spectra of 
delocalized systems in gas phase and in various dielectric environments [79]. 
There are two main modules: Molecule Building Option, and Calculation Option. 
Molecule Building, Modifications and Visualization: from Builder Tool you choose 
Tools . Any  molecule can be made from this toolbox by using the mouse. If you want to 
add atoms or molecular moieties (such as a benzene ring), select that, then right click on 
the visualizing panel to do so. Anything   you want to do to the molecule that you are 
building can be done by left click. You can select an atom or a bond (should turn yellow), 
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and pressing the Ctrl-key allows you to select multiple atoms/bonds [80]. Double-
Clicking on the molecule selects the whole molecule that was built. These operations can 
be performed only if the “selection” mode is clicked. Changing atoms and their state of 
hybridization or the nature of the bonds can be done by selecting them and doing a right-
click to choose from the various available options. Hydrogen atoms in the molecule can 
be filled by just clicking “H” button. 
In Arguslab many pre-made sample (molecules) are existed , and you may choose from 
them to use  as starting points. SAVE the file as a xyz coordinate file [81] . 
Many option are available in Arguslab , such as, rotations, translations, and zooming 
options through mouse clicks on icons on the upper left. In addition you can measure 
distances between atoms, and obtain angles/dihedral angle between three/four atoms in 
the molecule.  
In computational Chemistry many calculation can be done using Argus lab, such as  
semi-empirical calculations like MINDO and AMI, a single point energy calculation, 
quantum chemistry (Hartree-Fock SCF) and molecular mechanics calculations. Geometry 
optimization using QM methods is slower, semi-empirical methods like MINDO, AMI 
and PM3 are pretty fast. After geometry optimization, you can do UV-Vis spectra 
calculation, which would be done using MINDO-CI(S).  Save your calculation (.agl) after 
it is done. The outputs of the calculations can be found in the “molecule tree-view” 
option under “Tools” menu [82]. 
3.1.2 Gaussian 2009 
Gaussian program is an electronic structure package capable of predicting many 
properties of atoms, molecules and reactive systems, such as ; molecular energies , 
structures , vibrational frequencies , electron densities , by utilizing ab initio, density 
functional theory, semi-empirical, molecular mechanics, and various hybrid methods. 
 Gaussian 09 which is used by chemists, chemical engineers, biochemists, physicists and 
other scientists worldwide is the latest version of the Gaussian series of electronic 
structure programs. By using the fundamental laws of quantum mechanics, Gaussian 09 
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can predict the energies, molecular structures, vibrational frequencies and molecular 
properties of molecules and reactions in a wide variety of chemical environments. 
Gaussian 09’s models can be applied for both stable species and compounds which are 
difficult or impossible to observe experimentally (e.g., short-lived intermediates and 
transition structures) [83]. 
In Gaussian 09 you can find the most advanced modeling capabilities available today, so, 
it significantly expand the range of problems and systems which can be studied through 
it, many new features and enhancements which are available. 
Gaussian 09 provide many calculation method or function which include  MP2, HF, 
B3LYP, RHF that are found in basis set . In addition there is  many  calculation tool and 
Options , for example, SCF=QC, Freq=Raman, SP, Opt=(MaxCycle=N, TS) [84].  
 
3.1.3 Molden 
Molden  is a general molecular and electronic structure processing program. So, it can be 
described as a package for displaying molecular density from the ab initio packages 
GAMESS-UK , GAMESS-US and GAUSSIAN, and the Semi-empirical packages 
Mopac/Ampac, in addition it supports a number of other programs via the molden 
Format.  
All the information required from the GAMESS / GAUSSIAN output file can be read by 
molden. Also it is capable of displaying molecular orbitals, the electron density and the 
molecular minus atomic density [85].  
Either the spherically averaged atomic density or the oriented ground state atomic density 
can be subtracted for a number of standard basis sets. Molden supports contour plots, 3-d 
grid plots with hidden lines and a combination of both.  
It can write a variety of graphics instructions; postscript, XWindows, VRML, povray, 
OpenGL, tekronix4014, hpgl, hp2392 and Figure 
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 Atom typing and firing optimisation jobs can be done automatically and interactively 
from within Molden. The powerful Z-matrix editor which is available in Molden give full 
control over the geometry and allows to build molecules from scratch, including 
polypeptides.  
 
3.2 calculation method  
3.2.1 Method type 
There are roughly three types, or categories, of density functional methods.  
Local density approximation (LDA) methods assume that the density of the molecule is 
uniform throughout the molecule, and is typically not a very popular or useful method.  
Gradient corrected (GC) methods look to account for the non-uniformity of the electron 
density. 
Hybrid methods, as the name suggests, attempt to incorporate some of the more useful 
features from ab initio methods (specifically Hartree-Fock methods) with some of the 
improvements of DFT mathematics. Hybrid methods, such as B3LYP, tend to be the 
most commonly used methods for computational chemistry practitioners. 
 
3.2.2 6-Aminocaproic acid prodrug calculation method 
The Becke three-parameter, hybrid functional combined with the Lee, Yang, and Parr 
correlation functional, denoted by B3LYP, were employed in the calculations using 
density functional theory (DFT). The DFT calculations at B3LYP/6-31G (d,p) and 
B3LYP/311+G (d,p) levels, MP2 calculations, and all other calculation were carried out 
using the quantum chemical package Gaussian-2009 [86-89].  
The restricted Hartree-Fock method was used for all calculations were carried. The Argus 
Lab program was used to obtain the starting geometries of all calculated molecules [90] 
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and were initially optimized at the HF/6-31G level of theory, followed by optimization at 
the B3LYP/6-31G (d,p) level.  All internal rotations were included in total geometry 
optimizations. Second derivatives were estimated for all 3N-6 geometrical parameters 
during optimization. 
 An energy minimum (a stable compound or a reactive intermediate) has no negative 
vibrational force constant. The global minimum search was achieved by 360 rotation of 
the carboxylic group about the C6–C7 bond (i.e. variation of the dihedral angle 
O1C7C6C5). A transition state is a saddle point which has only one negative vibrational 
force constant [91]. At first  the normal reaction coordinate method was used to locate the 
transition states [92]. At this method the enthalpy changes were monitored by stepwise 
changing the interatomic distance between two specific atoms.  Then the energy gradient 
method at the B3LYP/6-31G (d,p) level of theory  was used to reoptimize the geometry at 
the highest point on the energy profile [92].  
The “reaction coordinate method” was used to calculate the activation energy  for 6-
aminocaproic acid ProD1-ProD5. In this method, one bond length is constrained for the 
appropriate degree of freedom while all other variables are freely optimized.  
The activation energy values for the proton transfer processes were calculated from the 
difference in energies of the global minimum structures (GM) and the derived transition 
states. Verification of the desired reactants and products was accomplished using the 
“intrinsic coordinate method” [92].  
The transition state structures were verified by their only one negative frequency. Full 
optimization of the transition states was accomplished after removing any constrains 
imposed while executing the energy profile. The activation energies obtained from DFT 
at B3LYP/6-31G (d,p) level of theory for 6- aminocaproic acid ProD1-ProD5 were 
calculated in gas phase and water phase  [93-96]. 
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Chapter Four 
Results and Discussion 
 
4.1 6-Aminocapproic acid prodrugs  
In order to design efficient prodrugs, there is a crucial need to further explore 
mechanisms for many intramolecular processes. An accurate design of an efficient 
chemical device that can be used as a prodrug linker which covalently linked to a drug 
that can chemically convert into the active parent drug, would be provided by exploration 
of the reaction mechanism.  
Many  prodrugs were designed  by using different prodrugs linkers by using the enzyme 
model of Kirby’s N-alkylmaleamic acids, such as tranexamic acid (to treat bleeding 
conditions) [97], cefuroxime (antibacterial) [67] and acyclovir (anti-viral drug to treat 
Herpes Simplex) prodrugs [77] . Additionally, exploring the mechanism of Menger’s 
Kemp acid enzyme model has led to the design of dopamine prodrugs for the treatment of 
Parkinson’s disease [98]. In addition , prodrugs for masking the bitter taste of atenolol 
(anti-hypertensive) [99, 100] and paracetamol (pain killer) were designed, synthesized 
and their kinetics were studied [101] .  
In addition the calculations study on Kirby’s acetals mechanism led to a design of novel 
prodrug such as, aza-nucleoside (to treat myelodysplastic syndromes) [102], 
phenylephrine (decongestant) [103], atovaquone [104-106] and statins (to treat high 
cholesterol levels in the blood) [76]. In these prodrugs, the hydroxyl group of the active 
drug was linked to the acetal moiety, upon the exposure of such prodrug to physiological 
environment; it has the potential to convert to its parent active form with rates that are 
solely determined on the structural features of the linker (Kirby’s acetal). 
The results of DFT calculation on Kirby enzyme model of N-alkylmaleamic acids which 
done by Karamans group were found to be in accordance with that reports by Kirby and 
Lancaster [61] and Kluger and Chin [73]. The ﬁndings demonstrated that the hydrolysis 
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of N-alkylmaleamic acids occurs by one mechanism, but the rate-limiting step was found 
to be largely dependent on the medium solvent and on the nature of the amine leaving 
group. According to these results two different rate-limiting steps were proposed: one 
involves the formation of a tetrahedral intermediate [74], and the second involves the 
dissociation of the tetrahedral intermediate [61, 73].  
The DFT calculations which were done in gas phase showed that the rate-limiting step for 
the hydrolysis of all maleamic acid amides studied is a tetrahedral formation regardless of 
the nature of the amine leaving group. On the other side, when the DFT calculations were 
done in a dielectric constant of 78.39 (water) the rate- limiting step for the hydrolysis of 
acid amides having primary amine as a leaving group was the dissociation of the 
tetrahedral intermediate, whereas the rate-limiting step for that having acyclovir or 
cefuroxime moieties was the tetrahedral intermediate formation. 
Since the bioavailability of 6-aminocaproic acid is only 24% due to the amino acid nature 
of the drug. At physiological pH, 6-aminocaproic acid will exist mainly in the ionized 
form; this ionization will decrease the ability of 6-aminocaproic acid to be transferred to 
the systemic blood circulation. This limited permeation results in poor bioavailability of 
the anti-bleeding drug. In my thesis I proposed five 6-aminocaproic acid prodrugs 
(Figure.5) based on proton transfers in Kirby’s N-alkylmaleamic acids enzyme model.  
The 6-aminocaproic acid prodrugs, ProD1- ProD5, have a carboxylic acid group 
(hydrophilic moiety) and a lipophilic moiety (the rest of the molecule), where the 
combination of both groups ensures a modified HLB. It should be noted that the HLB 
value will be determined upon the physiologic environment by which the prodrug is 
dissolved. For example, for prodrugs intended to be given as solutions or syrups to 
children or pediatrics , prodrug will reach the stomach and it will primarily exist in the 
carboxylic acid form whereas in the blood circulation the carboxylate anion form will be 
predominant. Because the linker (Kirby’s enzyme model) undergoes fast hydrolysis at 
low pH such as the stomach, it is planned that ProD1- ProD5 will be obtained as sodium 
or potassium salts and will be given to adults in the form of enteric coated tablets in order 
to assure release of the parent drug in the intestine (pH 6-8) and not in the stomach (pH 
1). On the other hand, the prodrugs when dissolved in the intestine they can exist in both 
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the carboxylate and free carboxylic acid forms (the ratio between the two forms will be 
determined on the pka value of the prodrug). The experimental determined pKa1 for 6-
aminocaproic acid ProD1- ProD5 linkers is in the range of 4-6. Therefore, it is expected 
that the pKas of the corresponding prodrugs will have similar pKa range as for the 
carboxylic linkers. Since the pH for the small intestine lies in the range of 5.5-6.8, the 
calculated unionized (acidic) /ionized ratio will be in the range of 10-50%. Although the 
percentage of the acidic form is not significantly high, we expect that these prodrugs to 
undergo an efficient proton transfer to yield the anti-fibrinolytic drug, 6-aminocaproic 
acid.  
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Figure 5: proposed 6-aminocaproic acid prodrugs 
 
4.2 General consideration 
 The orientation of the carboxylic acid affects the ground state energy of the N-
alkylmaleamic acid moiety especially when there is a possibility for engagement in 
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intramolecular hydrogen bonding. Therefore, the identification of the most stable 
conformer (global minimum) for each of Kirby’s N-alkylmaleamic acids 1–7 and 6- 
aminocaproic acid prodrugs ProD1–ProD5 are cruicially important. The global 
minimum search was achieved by 360 rotation of the carboxylic group about the C6–C7 
bond (i.e. variation of the dihedral angle O1C7C6C5) and calculation of the energies of 
the resulting conformers. 
In the DFT calculations of the starting geometries in 6-aminocapproic acid ProD1- 
ProD5, two different types of conformations were considered: one in which the 
carboxylic hydroxyl proton is syn to the amide group (Chart 1) and another in which it is 
anti (Chart 1). The global minimum search for 6-aminocapproic acid ProD1- ProD5 
revealed that all of them exist in the syn orientation (Figure 6a) except for ProD3 which 
exists in anti-orientation.  
 
 
Chart 1: Schematic representation of the reactants in the proton transfers of 6-
aminocaproic acid ProD1-ProD 5. GM is the global minimum structure, rGM is the O—H 
distance in the GM. α, is the angle of attack (hydrogen bonding) O1-H2-O3 in the GM. 
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4.3 Optimized structures for the entities involved in the acid-catalyzed hydrolysis of 
6-Aminocaproic acid prodrugs ProD1–ProD5 
4.3.1 Global minimum geometries (GM) 
Global minimum structures (GM): The global minimum structures for ProD1 GM–ProD 
5 GM are illustrated in Figure.6. Careful inspection of the calculated structures in 
Figure.6a  reveals that all the global minima of the reactants, except ProD3 GM, exist in 
conformation by which their carboxyl group is engaging intramolecularly in a hydrogen 
bonding net to form a seven-membered ring.  
Further, the DFT calculated angle α values in the global minimum structures (ProD1 
GM–ProD5 GM) were in the range of 58.4°, 51.6 °,13.6 °, 48.9 °, 48.8 °respectively 
whereas the DFT calculated hydrogen bonding length (rGM) were in range of 5.3 Å , 5.6 
Å, 5.7 Å, 4.8 Å, 4.5 Å, respectively.  
 
4.3.2 Transition state geometries (TS) 
The optimized DFT calculated transition state geometries for 6-aminocapproic acid 
ProD1 TS –ProD5 TS are illustrated in Figure 6b. 
 
4.3.3 Product geometries (P) 
The DFT calculated geometries for the products of 6- aminocapproic acid ProD1 P – 
ProD5 P are illustrated in Figure 6c. 
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Figure 6a: DFT optimized structures for the global minimum (GM) structures in the 
intramolecular proton transfer reaction of 6-aminocaproic acid ProD1-ProD5. 
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Figure 6b: DFT optimized structures for the transition state (TS) structures in the 
intramolecular proton transfer reaction of 6-aminocaproic acid ProD1-ProD5. 
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Figure 7c: DFT optimized structures for the linker product (P) structures in the 
intramolecular proton transfer reaction of 6-aminocaproic acid ProD1-ProD5. 
 
 
4.4 Mechanistic investigation The DFT at B3LYP/6-31G (d,p) level of kinetic and 
thermodynamic properties for 6-aminocaproic acid prodrugs ProD1–ProD5 
Kinetic and thermodynamic properties of 6-aminocaproic acid ProD1- ProD5 were 
calculated using the quantum chemical package Gaussian 2009 [86]. The values of 
enthalpy and entropy for all structures involved in the acid-catalyzed hydrolysis, global 
minimum (GM), transition states (TS), intermediates (INT) and products (P), were 
calculated in the gas phase and water (Table 1). 
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Table 1: DFT (B3LYP) calculated properties for the proton transfer reactions of in 6-
aminocaproic acid ProD1- ProD5 
 
Structure                         DFT enthalpy,H, In Hartree             DFT entropy, S, Cal/Mol-Kelvin          DFT  frequency cm                                                                                                                                                                               
 
6-amino proD1 GM              -821.0178119                               145.005                                                       -- 
6-amino proD1 TS                    -820.9576831                                      136.482                                                      -133.495          
6-amino proD2 GM                   -899.6624866                                  156.394                                                          --                         
6-amino proD2 TS                     -899.6097675                                     153.4                                                          -103.549          
6-amino proD3 GM                   -822.2561339                                 150.233                                                         --- 
6-amino proD3 TS                     -822.1959113                                    137.617                                                       -34.770 
6-amino proD4 GM                   -978.3185609                                  161.07                                                           ---  
6-amino proD4 TS                     -978.2508079                                    151.928                                                         -32.369 
6-amino proD5 GM                    -1017.636522                                167.313                                                          --- 
6-amino proD5 TS                      -1017.568501                                    158.812                                                        -31.110 
 
Using the calculated DFT enthalpy and entropy energy values for the global minimum 
structures, 1GM-7GM, and 6-aminocaproic acid, ProD1 GM- ProD5 GM, and their 
derived transition states, 1TS-7TS, and 6-aminocaproic acid, ProD1 TS- ProD5 TS, 
(Table 1) the enthalpy (ΔH‡), the entropy (TΔS‡), and the activation energy (ΔG‡) values 
for the proton transfers in these systems were calculated. The calculated values are listed 
in Table 2. 
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Table 2: DFT (B3LYP/6-31G (d,p) calculated kinetic and thermodynamic properties for 
the proton transfers in 6-aminocaproic acid ProD1-ProD5 and in 1-7 
 
System 
 
∆ES    
ES (INT- GM)     
log k 
(exp.) 
∆H‡ 
(GP) 
 
TΔS‡ 
(GP) 
∆G‡ 
(GP) 
∆H‡ 
(H2O) 
∆G‡ 
(H2O) 
6-amino proD1 3.2 -- 37.73 -2.531 39.26 39.84 40.37 
6-amino proD2 2.2 -- 33.08 -0.889 33.97 29.83 35.72 
6-amino proD3 11.8 -- 37.78 -3.746 41.53 40.47 44.21 
6-amino proD4 14.7 -- 42.51 -2.715 45.23 43.92 46.63 
6-amino proD5 14.0 -- 42.68 -2.52 45.20 44.15 46.67 
1 10.3 0 27.31  28.08 32.29 33.06 
2 5.3 4.37 13.93  16.42 17.56 20.05 
3 6.9 1.49 24.41  24.90 27.93 28.42 
4 15.6 -4.3 34.42  36.77 35.76 38.11 
5 10.1 2.73 13.25  17.41 18.96 23.12 
6 12.5 1.51 23.83  23.92 27.19 27.28 
7 12.4 1.64 24.86  25.03 27.38 27.55 
                                                              
 
4.4.1 The role of the strain energy on the rate of the proton transfer in processes 6-
aminocaproic acid ProD1-ProD5 
To test whether the discrepancy in the rates of 1–7 and 6-aminocapproic acid ProD1- 
ProD5 is a result of proximity orientation (difference in the distance between the two 
reactive centers) or stems from steric effects (strain energy) we computed using 
Allinger’s MM2 method [30] the strain energies for the reactants and intermediates in 1–
7 and 6-aminocapproic ProD1- ProD5. The rate of hydrolysis for 1-7 was found to be 
linearly correlated with the strain energy of the tetrahedral intermediate. The correlation 
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results illustrated graphically in Figure 7a demonstrate a good correlation between the 
experimental log krel and the MM2-calculated intermediate strain energy values (Es) 
with a correlation coefficient (r) of 0.93. The correlation results imply that the rate of the 
reaction for systems having less strained intermediates such as 2 and 5 are higher than 
that having more strained intermediates. This might be attributed to the fact that the 
transition state structures resemble that of the corresponding intermediate. 
 In addition the difference in MM2 strain energies of the intermediates and reactants (ΔEs 
= Es (INT-GM) are summarized in Table 2. The calculated MM2 (ΔEs) values for the 
reactions of 1-7 were examined for correlation with the experimental (log krel) values. 
The correlation results illustrated graphically in Figure 7c demonstrate a fair correlation 
between the experimental log krel and the MM2-calculated strain energy values (ΔEs) 
with a correlation coefficient (r) of 0.8. Examination of Figure 7c and Table 2 reveals that 
N-alkylmaleamic acids having small differences in the strain energies between their 
reactants and intermediates, such as system 2 the corresponding proton transfer rates are 
high and vice versa. 
In order to further support this conclusion, activation energy values for 1-7 as calculated 
in dielectric constant of 78.39 (water) (∆G‡ H2O, see Table 2) were examined for 
correlations with both log krel for system 1-7 and ΔEs for 6-aminoicapproic acid 
prodrugs.(Figures 7b and7d) with a correlation coefficient of 0.96 and 0.9, respectively.  
It should be emphasized, that an attempt to correlate the distance O3–H 2 (rGM) with ∆G
‡
 
for 6-aminiocapproic acid prodrugs failed to give any significant relationship between the 
two parameters.          
  ` . 
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Figure 7: (a) plot of the ES for intermediates of 1-7 N-alkylmaleamic acid   vs. relative 
rate (log k rel) .(b) Plot of the DFT calculated ∆G‡ vs. relative rate (log krel) in 1-7 N-
alkylmaleamic acid. (c) Plot of the MM2 calculated difference in strain energies between 
intermediates and reactants (ES (INT-GM)) vs. relative rate (log krel) in N-alkylmaleamic 
acids  1-7. (d) Plot of the DFT calculated ∆G‡ vs. MM2 calculated difference in strain 
energies between intermediates and reactants (ES (INT-GM)) in 6-aminocapproic acid ProD 
1- ProD5. 
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Chapter Five 
Conclusion and Future Direction 
 
5.1 Conclusion 
Based on Kirby`s enzyme model (Proton transfer in N-alkylmaleamic acids) five 
different 6-aminocaproic acid prodrugs were designed.  
The DFT calculation results revealed that the rate of a proton transfer in processes of 6-
aminocapprpic acid ProD1- ProD5 and 1-7 is governed by strain effect. The rate of 
hydrolysis was found to be linearly correlated with the strain energy difference between 
the intermediate and the reactant (Es INT-GM). Therefore it is expected that ProD2 having 
the lowest difference in strain energy will undergo a fastest proton transfer (high rate 
cleavage). 
 
5.2 Future Direction: 
According to the DFT calculations done for systems 1-7 and the designed 6-
aminocapproic acid prodrugs, it is recommended to synthesize 6-aminocapproic acid 
ProD2 using Kirby’s synthetic procedure.  
In vitro kinetic studies at different pH values should be made in order to be utilized for 
the in vivo pharmacokinetic studies which should be followed to determine the t1/2 values 
for the conversion of the 6-aminocapproic acid ProD2 to its parent drug, 6-
aminocapproic acid. Further, another pharmacokinetic parameter values will be 
calculated including oral bioavailability, and other pharmacokinetic parameters as 
deemed necessary. 
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Content 
1.Xyz Cartesian coordinates for the DFT optimized GM, TS, TET and P in 6-
aminocapproic acid ProD1- ProD5 
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ProD1 GM 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.532931 
 C     1.424338     0.000000     2.048619 
 C     1.449022     0.001607     3.564280 
 C     2.876657     0.023894     4.075430 
 C     2.914382    -0.105294     5.565064 
 O     3.846606     0.687959     6.163661 
 N    -1.305412     0.016177    -0.603066 
 C    -1.924858    -1.102842    -1.129567 
 C    -1.104794    -2.304605    -1.462468 
 C    -1.010999    -3.413685    -0.727501 
 C    -1.621380    -3.592690     0.595791 
 O    -1.868998    -4.894764     0.910427 
 O     2.246259    -0.824106     6.310587 
 O    -3.133858    -1.060584    -1.424881 
 O    -1.902644    -2.755685     1.457945 
 H     0.546439     0.919180    -0.359705 
 H     0.568080    -0.900755    -0.365212 
 H    -1.910204     0.754440    -0.317499 
 H    -0.547100    -0.901593     1.916484 
 H    -0.538491     0.905050     1.914513 
 H     1.967700     0.901068     1.662387 
 H     1.964685    -0.904079     1.665400 
 H     0.924218    -0.907668     3.958435 
 60 
 H     0.897285     0.896907     3.950628 
 H     3.391190     0.970538     3.767023 
 H     3.455137    -0.838743     3.650119 
 H     3.830175     0.548433     7.123062 
 H    -0.613622    -2.237091    -2.449300 
 H    -0.455860    -4.296262    -1.090341 
 H    -2.276827    -4.943045     1.789658  
 
ProD1 TET 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.458441 
 C     1.494603     0.000000     1.856934 
 C     2.235045    -0.051218     0.736887 
 C     1.324115    -0.060426    -0.440583 
 N    -0.724226    -1.151066     1.984793 
 C    -2.015131    -1.384524     1.360315 
 C    -2.796131    -2.521473     2.020613 
 C    -4.127935    -2.701742     1.319532 
 C    -4.915401    -3.839198     1.938897 
 C    -6.267103    -3.980594     1.270643 
 C    -7.093289    -5.095557     1.825863 
 O    -6.624325    -5.669460     2.968171 
 O    -0.550779     1.260562     1.777925 
 O     1.487493    -0.092766    -1.647923 
 O    -8.149637    -5.552060     1.381285 
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 H    -6.860971    -3.035228     1.390584 
 H    -6.142320    -4.166501     0.170737 
 H    -4.345025    -4.798455     1.838985 
 H    -5.057469    -3.656567     3.035596 
 H    -4.721141    -1.753077     1.386338 
 H    -3.955431    -2.910436     0.231869 
 H    -2.206905    -3.472355     1.964747 
 H    -2.968949    -2.295859     3.104279 
 H    -2.653531    -0.453430     1.375880 
 H    -1.821335    -1.641813     0.280904 
 H    -7.228107    -6.374945     3.249061 
 H    -0.808989    -1.051399     2.977954 
 H     1.792975     0.041066     2.901788 
 H     3.317584    -0.073507     0.615181 
 H    -1.258186     1.451377     1.147762  
 
ProD1 TS 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.441703 
 C     1.476184     0.000000     1.803496 
 C     2.210401    -0.013647     0.693377 
 C     1.294887    -0.041256    -0.477748 
 N    -0.830099    -1.526639     2.052663 
 C    -2.244939    -1.693660     1.679897 
 C    -2.744904    -3.067452     2.127311 
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 C    -4.201603    -3.328628     1.727334 
 C    -4.710244    -4.700483     2.185605 
 C    -6.167708    -4.958730     1.761479 
 C    -6.688309    -6.310675     2.194674 
 O    -6.640433    -6.461897     3.544688 
 O    -0.670081     1.156445     1.890960 
 O     1.550555    -0.077346    -1.652041 
 O    -7.105209    -7.180856     1.463114 
 H    -6.816667    -4.190834     2.201806 
 H    -6.275355    -4.907796     0.675402 
 H    -4.068090    -5.486212     1.767255 
 H    -4.633738    -4.781712     3.275652 
 H    -4.845631    -2.543785     2.148331 
 H    -4.297790    -3.249556     0.635798 
 H    -2.091984    -3.836734     1.697588 
 H    -2.648797    -3.153806     3.219891 
 H    -2.881617    -0.900248     2.098774 
 H    -2.302827    -1.612689     0.590681 
 H    -6.985021    -7.353085     3.724103 
 H    -0.719777    -1.579059     3.062192 
 H     1.810668     0.020601     2.834007 
 H     3.286265    -0.013023     0.582675 
 H    -0.349401     1.913499     1.379053  
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ProD1 product 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.399247 
 C     1.425669     0.000000     1.829791 
 C     2.192707    -0.090291     0.742070 
 C     1.315940    -0.111665    -0.454867 
 N    -1.048598    -2.706060     2.159301 
 C    -2.419872    -2.802630     1.652480 
 C    -3.052829    -4.130616     2.089751 
 C    -4.466799    -4.331874     1.530541 
 C    -5.101935    -5.654572     1.975379 
 C    -6.518187    -5.848489     1.401886 
 C    -7.159477    -7.151037     1.824139 
 O    -7.292690    -7.233118     3.174387 
 O    -0.756303     0.998624     1.939957 
 O     1.583591    -0.196902    -1.620865 
 O    -7.521561    -8.039212     1.085125 
 H    -7.163245    -5.028067     1.741027 
 H    -6.503829    -5.837978     0.309394 
 H    -4.465891    -6.490541     1.657284 
 H    -5.149428    -5.696091     3.069291 
 H    -5.109844    -3.497858     1.845881 
 H    -4.432581    -4.293876     0.433123 
 H    -2.398197    -4.948295     1.766133 
 H    -3.084781    -4.173392     3.187738 
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 H    -3.082041    -1.976862     1.981411 
 H    -2.375657    -2.763755     0.558347 
 H    -7.700612    -8.098130     3.348971 
 H    -1.106791    -2.577984     3.174798 
 H     1.721516     0.044022     2.869578 
 H     3.269514    -0.148147     0.667635 
 H    -0.548119    -3.552534     1.937787 
 
ProD2 GM 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.484713 
 C     1.143386     0.000000     2.194444 
 C     2.480211     0.027264     1.545318 
 C    -1.374847     0.050331     2.087854 
 O    -2.184596     0.931338     1.737269 
 N    -1.713788    -0.937432     2.982212 
 C    -3.003393    -0.989530     3.620950 
 C    -3.617075    -2.391232     3.667959 
 C    -2.860105    -3.323506     4.590889 
 C    -3.533526    -4.680505     4.655313 
 C    -2.776248    -5.611636     5.581083 
 C    -3.349633    -6.992200     5.549921 
 O    -3.055301    -7.733304     6.655411 
 O    -4.023473    -7.550464     4.681842 
 C     1.183329    -0.023107     3.669979 
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 O     1.797690     1.049757     4.236733 
 O     0.784979    -0.897788     4.446246 
 H    -3.706766    -0.304511     3.066662 
 H    -2.904117    -0.604732     4.676995 
 H    -1.011023    -1.553063     3.321799 
 H    -3.662781    -2.830460     2.638999 
 H    -4.671570    -2.280765     4.032305 
 H    -2.809482    -2.877590     5.618088 
 H    -1.805721    -3.450993     4.232999 
 H    -3.585193    -5.132997     3.630566 
 H    -4.587527    -4.566113     5.017775 
 H    -2.797990    -5.226975     6.633821 
 H    -1.700577    -5.685908     5.268325 
 H    -3.439597    -8.619060     6.568004 
 H    -0.986805     0.345895    -0.395877 
 H     0.199824    -1.034132    -0.376686 
 H     0.797009     0.677502    -0.395105 
 H     2.622093     0.999332     1.009153 
 H     2.563284    -0.801750     0.799803 
 H     3.298336    -0.079643     2.297293 
 H     1.796854     0.950499     5.202651 
 
ProD2 TET 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.456499 
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 C     1.496767     0.000000     1.860246 
 C     2.241139    -0.048847     0.731961 
 C     1.322559    -0.056771    -0.441933 
 N    -0.728577    -1.150236     1.978721 
 C    -2.054166    -1.326133     1.411421 
 C    -2.824107    -2.483033     2.049613 
 C    -4.196058    -2.596577     1.414827 
 C    -4.957303    -3.777959     1.982566 
 C    -6.340447    -3.867946     1.372373 
 C    -7.157508    -4.998765     1.908687 
 O    -6.621292    -5.670337     2.964902 
 O    -0.557373     1.259820     1.773642 
 C     1.888385     0.057899     3.267452 
 C     3.696525    -0.078666     0.559032 
 O     1.480356    -0.080298    -1.651032 
 O    -8.259332    -5.391790     1.516805 
 H    -6.913832    -2.922136     1.566182 
 H    -6.269156    -4.001069     0.260016 
 H    -4.396462    -4.726975     1.781264 
 H    -5.044002    -3.679970     3.095747 
 H    -4.774538    -1.653599     1.595131 
 H    -4.089786    -2.714069     0.305239 
 H    -2.260411    -3.440578     1.907889 
 H    -2.932917    -2.316466     3.152121 
 H    -2.671791    -0.385918     1.509165 
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 H    -1.919926    -1.528646     0.311459 
 H    -7.225007    -6.377913     3.240584 
 H    -0.759857    -1.084305     2.977720 
 H    -1.244060     1.459226     1.123543 
 H     4.213547     0.376135     1.439097 
 H     3.988998     0.482689    -0.363120 
 H     4.048526    -1.135690     0.449308 
 H     2.988427     0.223893     3.374273 
 H     1.622420    -0.900776     3.781291 
 H     1.344627     0.894248     3.776058 
 
ProD2 TS 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.436163 
 C     1.478051     0.000000     1.821800 
 C     2.219472    -0.017000     0.704627 
 C     1.298540    -0.044935    -0.461603 
 N    -0.858891    -1.512491     2.042498 
 C    -2.269437    -1.657094     1.644565 
 C    -2.823735    -2.987261     2.154832 
 C    -4.279682    -3.222724     1.736288 
 C    -4.852162    -4.538601     2.275616 
 C    -6.310034    -4.768890     1.836007 
 C    -6.895132    -6.061762     2.357539 
 O    -6.900277    -6.101723     3.716393 
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 O    -0.668724     1.165010     1.883178 
 C     1.889905     0.041532     3.255257 
 C     3.698829    -0.021330     0.496536 
 O     1.565226    -0.080501    -1.636036 
 O    -7.316860    -6.975772     1.684491 
 H    -6.934289    -3.943686     2.201576 
 H    -6.391617    -4.796944     0.746777 
 H    -4.233766    -5.376521     1.928603 
 H    -4.802521    -4.545600     3.370279 
 H    -4.901927    -2.386773     2.085633 
 H    -4.347748    -3.216395     0.639802 
 H    -2.188541    -3.801415     1.785082 
 H    -2.755224    -3.014299     3.252753 
 H    -2.889912    -0.823385     2.005186 
 H    -2.301597    -1.634038     0.551381 
 H    -7.282927    -6.963014     3.954876 
 H    -0.779451    -1.546231     3.055763 
 H    -0.343773     1.914232     1.362803 
 H     4.244804     0.075050     1.437651 
 H     3.996582     0.795681    -0.168684 
 H     4.012768    -0.950559     0.008566 
 H     2.961381     0.221029     3.366267 
 H     1.658922    -0.906836     3.757300 
 H     1.342358     0.830261     3.782455 
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ProD2 product 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.436163 
 C     1.478051     0.000000     1.821800 
 C     2.219472    -0.017000     0.704627 
 C     1.298540    -0.044935    -0.461603 
 N    -1.398845    -2.463340     2.423680 
 C    -2.809392    -2.607943     2.025746 
 C    -3.363689    -3.938110     2.536013 
 C    -4.819637    -4.173573     2.117469 
 C    -5.392116    -5.489450     2.656798 
 C    -6.849988    -5.719739     2.217188 
 C    -7.435086    -7.012611     2.738721 
 O    -7.440231    -7.052573     4.097574 
 O    -0.668724     1.165010     1.883178 
 C     1.889905     0.041532     3.255257 
 C     3.698829    -0.021330     0.496536 
 O     1.565226    -0.080501    -1.636036 
 O    -7.856814    -7.926621     2.065673 
 H    -7.474243    -4.894536     2.582757 
 H    -6.931572    -5.747793     1.127959 
 H    -4.773721    -6.327370     2.309784 
 H    -5.342475    -5.496449     3.751460 
 H    -5.441881    -3.337622     2.466814 
 H    -4.887702    -4.167244     1.020983 
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 H    -2.728496    -4.752264     2.166264 
 H    -3.295178    -3.965148     3.633934 
 H    -3.429866    -1.774234     2.386367 
 H    -2.841552    -2.584887     0.932562 
 H    -7.822881    -7.913863     4.336057 
 H    -1.319405    -2.497080     3.436944 
 H     4.244804     0.075050     1.437651 
 H     3.996582     0.795681    -0.168684 
 H     4.012768    -0.950559     0.008566 
 H     2.961381     0.221029     3.366267 
 H     1.658922    -0.906836     3.757300 
 H     1.342358     0.830261     3.782455 
 H    -0.858044    -3.213638     2.022868 
 
ProD3 GM 
C     0.000000     0.000000     0.000000 
 N     0.000000     0.000000     1.435094 
 C     1.122513     0.000000     2.239060 
 O     0.970609    -0.140771     3.469139 
 C    -0.678186    -1.226103    -0.624865 
 C    -0.682332    -1.099325    -2.134957 
 C    -1.435622    -2.251175    -2.769721 
 C    -1.393807    -2.153759    -4.281489 
 C    -2.210718    -3.232932    -4.917023 
 O    -2.258737    -3.151810    -6.276693 
 71 
 O    -2.832994    -4.163041    -4.400978 
 C     2.494134     0.205715     1.625820 
 C     3.542995     0.319358     2.713088 
 C     4.925008     0.488039     2.173696 
 O     5.065668     0.275732     0.833878 
 O     5.952606     0.786216     2.785787 
 H    -0.546715     0.924418    -0.348977 
 H     1.054388     0.063800    -0.387078 
 H    -1.730886    -1.314726    -0.251640 
 H    -0.138054    -2.160046    -0.325046 
 H     0.371797    -1.081053    -2.515317 
 H    -1.160115    -0.129404    -2.431315 
 H    -2.502073    -2.248067    -2.424100 
 H    -0.990971    -3.227392    -2.445246 
 H    -0.339978    -2.245365    -4.654788 
 H    -1.789195    -1.162046    -4.625690 
 H    -0.871247    -0.179412     1.880323 
 H     2.498241     1.134945     0.999195 
 H     2.735426    -0.660103     0.954852 
 H     3.531111    -0.600057     3.359439 
 H     3.316114     1.191183     3.383716 
 H     5.994799     0.393746     0.581614 
 H    -2.799950    -3.875396    -6.628465 
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ProD3 TET 
O     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.448002 
 C     1.491705     0.000000     1.919394 
 C     2.303160    -0.150964     0.639050 
 C     1.294328    -0.104835    -0.475834 
 N    -0.767897    -1.133914     1.956966 
 C    -2.042402    -1.353107     1.296883 
 C    -2.848641    -2.486334     1.932897 
 C    -4.141766    -2.691635     1.169216 
 C    -4.924299    -3.856160     1.743016 
 C    -6.243467    -4.028320     1.019640 
 C    -7.046682    -5.187372     1.515417 
 O    -6.567105    -5.808958     2.628058 
 O    -0.543217     1.271002     1.751540 
 O     1.407647    -0.132760    -1.691856 
 O    -8.091325    -5.644637     1.044642 
 H    -6.876322    -3.108502     1.138185 
 H    -6.070664    -4.182726    -0.078690 
 H    -4.324728    -4.799102     1.656881 
 H    -5.115495    -3.690146     2.834829 
 H    -4.761261    -1.758956     1.217475 
 H    -3.915398    -2.885160     0.088594 
 H    -2.250076    -3.433108     1.922874 
 H    -3.078169    -2.244782     3.002461 
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 H    -2.674781    -0.417909     1.296676 
 H    -1.822240    -1.609244     0.222360 
 H    -7.155646    -6.541051     2.870326 
 H    -0.881356    -1.026790     2.946205 
 H     1.693191    -0.833488     2.631341 
 H     1.703549     0.970128     2.430308 
 H     2.850788    -1.125303     0.605515 
 H     3.045732     0.674699     0.512894 
 H    -1.281348     1.442975     1.153379 
 
ProD3 TS 
N     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.842000 
 O     1.383176     0.000000     2.265672 
 C     1.807401    -1.270532     2.561618 
 O     2.943021    -1.509068     2.870830 
 C     0.633881    -2.231433     2.422310 
 C    -0.586650    -1.309805     2.387586 
 O    -0.641233     1.084857     2.452449 
 C     0.654208     1.138025    -0.656646 
 C     0.677669     0.942429    -2.173572 
 C     1.398271     2.076820    -2.911131 
 C     1.405790     1.890046    -4.432810 
 C     2.147386     3.026399    -5.160970 
 C     2.171682     2.855880    -6.663330 
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 O     3.161888     2.747683    -7.351502 
 O     0.918216     2.831595    -7.188308 
 H     1.033296     2.711351    -8.146162 
 H     3.186455     3.092032    -4.829530 
 H     1.658374     3.982883    -4.936799 
 H     0.377251     1.835671    -4.806760 
 H     1.880737     0.932180    -4.681106 
 H     2.432256     2.147218    -2.546636 
 H     0.921671     3.036781    -2.666829 
 H    -0.353901     0.863747    -2.546698 
 H     1.160589    -0.017385    -2.392700 
 H     1.678084     1.194379    -0.274552 
 H     0.166469     2.103133    -0.425126 
 H    -0.965792    -0.070584    -0.313260 
 H    -0.151260     1.889362     2.230243 
 H    -1.404786    -1.678509     1.765263 
 H    -0.970396    -1.116847     3.392057 
 H     0.643185    -2.957097     3.237382 
 H     0.760507    -2.776150     1.480984 
 
ProD3 product 
N     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     3.000000 
 O     1.383176     0.000000     3.423672 
 C     1.807401    -1.270532     3.719618 
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 O     2.943021    -1.509068     4.028830 
 C     0.633881    -2.231433     3.580310 
 C    -0.586650    -1.309805     3.545586 
 O    -0.641233     1.084857     3.610449 
 C     0.654208     1.138025    -0.656646 
 C     0.677669     0.942429    -2.173572 
 C     1.398271     2.076820    -2.911131 
 C     1.405790     1.890046    -4.432810 
 C     2.147386     3.026399    -5.160970 
 C     2.171682     2.855880    -6.663330 
 O     3.161888     2.747683    -7.351502 
 O     0.918216     2.831595    -7.188308 
 H     1.033296     2.711351    -8.146162 
 H     3.186455     3.092032    -4.829530 
 H     1.658374     3.982883    -4.936799 
 H     0.377251     1.835671    -4.806760 
 H     1.880737     0.932180    -4.681106 
 H     2.432256     2.147218    -2.546636 
 H     0.921671     3.036781    -2.666829 
 H    -0.353901     0.863747    -2.546698 
 H     1.160589    -0.017385    -2.392700 
 H     1.678084     1.194379    -0.274552 
 H     0.166469     2.103133    -0.425126 
 H    -0.965792    -0.070584    -0.313260 
 H    -1.404786    -1.678509     2.923263 
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 H    -0.970396    -1.116847     4.550057 
 H     0.643185    -2.957097     4.395382 
 H     0.760507    -2.776150     2.638984 
 H     0.482162    -0.851045    -0.243531 
 
ProD4 GM 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.527914 
 C     1.426194     0.000000     2.087121 
 C     2.247814    -1.141045     1.491725 
 C     2.232305    -1.112185    -0.022453 
 C     0.811317    -1.155690    -0.548507 
 C     1.374132    -0.210269     3.601382 
 O     0.965153    -1.290149     4.076405 
 C    -0.744347     1.226321     1.988575 
 O    -2.073278     1.023987     2.191472 
 N     1.756849     0.785292     4.474296 
 C     2.317257     2.053966     4.104526 
 C     3.803029     2.039007     3.728209 
 C     4.690725     1.721807     4.913155 
 C     6.154582     1.775332     4.522812 
 C     7.039563     1.449630     5.709495 
 C     8.486547     1.593777     5.361018 
 O     9.321406     0.913837     6.196467 
 O     9.022088     2.234147     4.454167 
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 O    -0.326246     2.371867     2.178578 
 H     1.728328     2.479911     3.240560 
 H     2.179790     2.750637     4.980399 
 H     3.986064     1.295690     2.909953 
 H     4.060950     3.052888     3.326279 
 H     4.446196     0.702976     5.310737 
 H     4.495326     2.456241     5.737266 
 H     6.355310     1.047088     3.695191 
 H     6.412504     2.794574     4.133250 
 H     6.850872     0.404818     6.069550 
 H     6.824905     2.146973     6.562393 
 H    10.242042     1.057301     5.928223 
 H     1.787239     0.542261     5.437973 
 H     1.912773     0.977527     1.821887 
 H    -0.537427    -0.915420     1.905412 
 H    -2.491374     1.850693     2.479413 
 H     1.835312    -2.117760     1.858907 
 H     3.302183    -1.056306     1.860746 
 H     2.740147    -0.183444    -0.389658 
 H     2.807574    -1.989218    -0.415190 
 H     0.331355    -2.125401    -0.257185 
 H     0.819623    -1.103620    -1.667120 
 H     0.426015     0.968560    -0.369882 
 H    -1.057902    -0.071156    -0.361862 
 
 78 
ProD4 TET 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.508790 
 C     1.456209     0.000000     2.016665 
 C     2.095967     1.323716     1.678583 
 C     2.075119     1.477528     0.160549 
 C     0.700718     1.275035    -0.460745 
 C    -0.618075    -1.121938     2.300407 
 O     0.076438    -1.300629     3.483531 
 C     1.271868    -0.423409     3.508554 
 N     2.406601    -1.118686     4.086854 
 C     2.290517    -1.494385     5.485138 
 C     2.883335    -0.451195     6.438787 
 C     2.757638    -0.937616     7.868760 
 C     3.374008     0.053544     8.835677 
 C     3.323443    -0.483843    10.252532 
 C     3.904361     0.493330    11.223775 
 O     4.445658    -0.090443    12.330077 
 O     0.810442     0.680036     4.241110 
 O    -1.588350    -1.845002     2.132639 
 O     3.952935     1.723772    11.174702 
 H     1.214869    -1.676997     5.772038 
 H     2.845679    -2.462452     5.638048 
 H     3.961239    -0.276916     6.189641 
 H     2.353886     0.528610     6.318746 
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 H     3.267812    -1.930386     7.974220 
 H     1.677201    -1.090846     8.124593 
 H     4.438303     0.253898     8.547819 
 H     2.829404     1.032095     8.786015 
 H     3.880517    -1.453933    10.327165 
 H     2.261150    -0.675037    10.560094 
 H     4.791743     0.591898    12.925565 
 H     2.637555    -1.907566     3.517521 
 H     2.030022    -0.818168     1.500874 
 H    -0.515998     0.937773     1.870426 
 H     1.536408     2.159282     2.170386 
 H     3.150489     1.354503     2.051144 
 H     2.788157     0.736275    -0.285811 
 H     2.444648     2.501046    -0.104856 
 H     0.052146     2.153154    -0.205711 
 H     0.806358     1.248094    -1.575417 
 H     0.533055    -0.901202    -0.394770 
 H    -1.047899    -0.025098    -0.391656 
 H     0.515767     0.371785     5.109253 
 
ProD4 TS 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.522230 
 C     1.423702     0.000000     2.094786 
 C     2.179636     1.259935     1.695350 
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 C     2.207690     1.354504     0.149006 
 C     0.793346     1.238409    -0.469706 
 C    -0.643761    -1.128262     2.299657 
 O     0.037458    -1.233821     3.515515 
 C     1.141021    -0.341599     3.545038 
 N     2.558471    -1.314696     4.206009 
 C     2.109684    -2.387918     5.094718 
 C     1.376534    -1.992732     6.387722 
 C     1.090894    -3.187727     7.306433 
 C     0.353830    -2.798572     8.592659 
 C     0.068413    -3.998258     9.496701 
 C    -0.648026    -3.622841    10.774826 
 O    -0.896969    -4.712929    11.544037 
 O     0.900845     0.765556     4.319759 
 O    -1.572609    -1.838597     2.038735 
 O    -0.974799    -2.505052    11.108462 
 H     1.478323    -3.065922     4.510844 
 H     3.010975    -2.961196     5.362062 
 H     0.421013    -1.513993     6.131892 
 H     1.977152    -1.249455     6.933481 
 H     2.039281    -3.681739     7.561655 
 H     0.499394    -3.931569     6.754768 
 H    -0.593007    -2.303853     8.346153 
 H     0.939907    -2.060187     9.152455 
 H     0.994388    -4.517467     9.776405 
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 H    -0.542030    -4.751094     8.981686 
 H    -1.354249    -4.383062    12.335999 
 H     3.001664    -0.585859     4.771273 
 H     1.954253    -0.872842     1.695969 
 H    -0.504844     0.913850     1.875992 
 H     3.203974     1.243126     2.084582 
 H     1.686301     2.144062     2.119395 
 H     2.794171     0.496045    -0.213166 
 H     0.878268     1.232847    -1.562663 
 H     0.221468     2.141592    -0.210392 
 H     0.470974    -0.919454    -0.369970 
 H    -1.020493     0.018597    -0.395745 
 H     0.555962     0.467878     5.174497 
 H     2.651277     2.303479    -0.148648 
 
ProD4 product 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.522230 
 C     1.423702     0.000000     2.094786 
 C     2.179636     1.259935     1.695350 
 C     2.207690     1.354504     0.149006 
 C     0.793346     1.238409    -0.469706 
 C    -0.643761    -1.128262     2.299657 
 O     0.037458    -1.233821     3.515515 
 C     1.141021    -0.341599     3.545038 
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 N     3.449571    -1.926448     4.621538 
 C     3.000784    -2.999670     5.510247 
 C     2.267634    -2.604484     6.803251 
 C     1.981995    -3.799479     7.721962 
 C     1.244930    -3.410323     9.008188 
 C     0.959513    -4.610010     9.912230 
 C     0.243074    -4.234592    11.190355 
 O    -0.005868    -5.324681    11.959566 
 O     0.900845     0.765556     4.319759 
 O    -1.572609    -1.838597     2.038735 
 O    -0.083698    -3.116803    11.523991 
 H     2.369423    -3.677674     4.926373 
 H     3.902075    -3.572947     5.777591 
 H     1.312113    -2.125745     6.547421 
 H     2.868253    -1.861207     7.349010 
 H     2.930382    -4.293490     7.977184 
 H     1.390494    -4.543320     7.170297 
 H     0.298093    -2.915604     8.761682 
 H     1.831007    -2.671939     9.567984 
 H     1.885488    -5.129219    10.191933 
 H     0.349070    -5.362846     9.397215 
 H    -0.463149    -4.994814    12.751528 
 H     3.892764    -1.197611     5.186802 
 H     1.954253    -0.872842     1.695969 
 H    -0.504844     0.913850     1.875992 
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 H     3.203974     1.243126     2.084582 
 H     1.686301     2.144062     2.119395 
 H     2.794171     0.496045    -0.213166 
 H     0.878268     1.232847    -1.562663 
 H     0.221468     2.141592    -0.210392 
 H     0.470974    -0.919454    -0.369970 
 H    -1.020493     0.018597    -0.395745 
 H     2.651277     2.303479    -0.148648 
 H     4.111833    -2.295259     3.957120 
 
ProD5 GM 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.527262 
 C     1.426344     0.000000     2.086585 
 C     2.253713    -1.129221     1.481012 
 C     2.252862    -1.078975    -0.039829 
 C     0.822046    -1.142705    -0.556974 
 C     1.396268    -0.209146     3.600550 
 O     0.462389    -0.830318     4.147719 
 C    -0.742898     1.227907     1.987462 
 O    -2.090961     1.061691     2.058581 
 C     3.079572    -2.215038    -0.606123 
 N     2.397522     0.295345     4.405445 
 C     3.643126     0.854223     3.967709 
 C     4.861114    -0.064991     4.124804 
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 C     5.164818    -0.374737     5.575585 
 C     6.450482    -1.168619     5.699097 
 C     6.733515    -1.510750     7.148185 
 C     8.064573    -2.175546     7.297439 
 O     8.215455    -2.840409     8.477333 
 O     9.028145    -2.198452     6.529068 
 O    -0.308596     2.346429     2.272719 
 H     3.570319     1.153494     2.885752 
 H     3.827593     1.791424     4.569341 
 H     5.738341     0.456989     3.661767 
 H     4.703141    -1.019917     3.561283 
 H     4.323062    -0.960134     6.028435 
 H     5.255747     0.581140     6.153943 
 H     7.308643    -0.581655     5.279344 
 H     6.373377    -2.112109     5.099609 
 H     5.938850    -2.186964     7.558390 
 H     6.745683    -0.580823     7.776477 
 H     9.099343    -3.236918     8.519248 
 H     2.329914     0.084306     5.376001 
 H     1.886691     0.994779     1.834817 
 H    -0.544353    -0.908901     1.910664 
 H    -2.504714     1.881188     2.371580 
 H     1.840650    -2.114172     1.821874 
 H     3.307056    -1.050962     1.856960 
 H     2.707852    -0.103040    -0.366887 
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 H     0.361141    -2.121481    -0.266161 
 H     0.824316    -1.087871    -1.675547 
 H    -1.058360    -0.082719    -0.358853 
 H     0.412880     0.974150    -0.370684 
 H     4.129040    -2.155449    -0.232564 
 H     3.095048    -2.161664    -1.720239 
 H     2.652005    -3.200493    -0.304898 
 
ProD5 TET 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.508657 
 C     1.456191     0.000000     2.013250 
 C     2.091409     1.325632     1.678004 
 C     2.081885     1.478735     0.152292 
 C     0.694560     1.278566    -0.459038 
 C    -0.614449    -1.117702     2.306071 
 O     0.080062    -1.280884     3.501294 
 C     1.272817    -0.437366     3.502232 
 N     2.412117    -1.171310     4.037324 
 C     2.220267    -1.856189     5.297244 
 C     2.465214    -1.030755     6.564528 
 C     2.331885    -1.903857     7.795498 
 C     2.548710    -1.093399     9.057913 
 C     2.478392    -1.977814    10.287045 
 C     2.544547    -1.164604    11.540410 
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 O     2.957887    -1.869471    12.631029 
 O     0.854504     0.681358     4.260656 
 O    -1.585754    -1.841808     2.160498 
 C     2.624812     2.840260    -0.232279 
 O     2.272621     0.022963    11.727730 
 H     1.178016    -2.280395     5.326642 
 H     2.942980    -2.721604     5.292252 
 H     1.732810    -0.184766     6.620688 
 H     3.490705    -0.579776     6.535993 
 H     3.080561    -2.736708     7.748053 
 H     1.313956    -2.372232     7.817584 
 H     1.774549    -0.285708     9.134794 
 H     3.547880    -0.587751     9.018151 
 H     3.314978    -2.724082    10.287756 
 H     1.512452    -2.549318    10.305194 
 H     2.964375    -1.292523    13.410344 
 H     3.201857    -0.556418     4.062659 
 H     2.029921    -0.819502     1.497802 
 H    -0.517067     0.937946     1.869304 
 H     3.144626     1.363127     2.053107 
 H     1.527291     2.162525     2.161824 
 H     2.761393     0.687989    -0.273251 
 H     0.793432     1.258065    -1.574452 
 H     0.050222     2.156793    -0.194220 
 H     0.537961    -0.898441    -0.394425 
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 H    -1.047313    -0.029218    -0.392894 
 H     0.398053     0.361502     5.049470 
 H     1.976158     3.651688     0.174382 
 H     2.664116     2.942252    -1.342392 
 H     3.654877     2.974424     0.174260 
 
ProD5 TS 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.522633 
 C     1.417506     0.000000     2.096984 
 C     2.166841     1.267090     1.697318 
 C     2.198000     1.364952     0.151005 
 C     0.785628     1.242245    -0.469414 
 C    -0.657344    -1.125821     2.296074 
 O     0.014341    -1.266669     3.493351 
 C     1.136087    -0.341212     3.566622 
 N     2.528324    -1.228990     4.383009 
 C     2.388592    -1.607850     5.794068 
 C     2.814100    -0.543729     6.819391 
 C     2.679390    -1.029416     8.267433 
 C     3.141450     0.009116     9.295786 
 C     2.997509    -0.481798    10.736739 
 C     3.461295     0.531789    11.759445 
 O     3.292794     0.072950    13.025388 
 O     0.667077     0.832298     4.216147 
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 O    -1.605667    -1.808218     2.014055 
 C     2.893549     2.650560    -0.309934 
 O     3.930183     1.622871    11.521014 
 H     1.346659    -1.907120     5.953378 
 H     2.985049    -2.515010     5.955709 
 H     2.229016     0.371037     6.671259 
 H     3.860713    -0.266173     6.626574 
 H     3.258190    -1.955341     8.395953 
 H     1.631959    -1.299976     8.464694 
 H     2.570252     0.936834     9.173726 
 H     4.188091     0.278095     9.111877 
 H     3.568621    -1.404529    10.903224 
 H     1.956575    -0.739082    10.971073 
 H     3.615201     0.778385    13.611578 
 H     3.394797    -0.726092     4.217154 
 H     1.949807    -0.872202     1.694368 
 H    -0.499105     0.915670     1.875721 
 H     3.194977     1.269332     2.082099 
 H     1.663758     2.143466     2.124675 
 H     2.790021     0.510696    -0.212797 
 H     0.873078     1.239538    -1.562308 
 H     0.209579     2.142379    -0.208881 
 H     0.473813    -0.916936    -0.373154 
 H    -1.021487     0.013657    -0.393191 
 H     0.110961     0.549260     4.955675 
 89 
 H     2.341324     3.536944     0.024243 
 H     2.964005     2.695147    -1.401909 
 H     3.909396     2.720321     0.093801 
 
ProD5 product 
C     0.000000     0.000000     0.000000 
 C     0.000000     0.000000     1.522633 
 C     1.417506     0.000000     2.096984 
 C     2.166841     1.267090     1.697318 
 C     2.198000     1.364952     0.151005 
 C     0.785628     1.242245    -0.469414 
 C    -0.657344    -1.125821     2.296074 
 O     0.014341    -1.266669     3.493351 
 C     1.136087    -0.341212     3.566622 
 N     3.403575    -1.787105     4.896243 
 C     3.263843    -2.165965     6.307301 
 C     3.689350    -1.101844     7.332624 
 C     3.554641    -1.587531     8.780666 
 C     4.016701    -0.548999     9.809019 
 C     3.872759    -1.039912    11.249972 
 C     4.336546    -0.026326    12.272678 
 O     4.168045    -0.485164    13.538622 
 O     0.667077     0.832298     4.216147 
 O    -1.605667    -1.808218     2.014055 
 C     2.893549     2.650560    -0.309934 
 O     4.805433     1.064756    12.034247 
 90 
 H     2.221910    -2.465235     6.466611 
 H     3.860299    -3.073125     6.468942 
 H     3.104267    -0.187078     7.184493 
 H     4.735963    -0.824288     7.139808 
 H     4.133440    -2.513456     8.909187 
 H     2.507210    -1.858091     8.977927 
 H     3.445502     0.378719     9.686959 
 H     5.063341    -0.280020     9.625110 
 H     4.443872    -1.962644    11.416458 
 H     2.831825    -1.297197    11.484306 
 H     4.490451     0.220270    14.124811 
 H     4.270047    -1.284207     4.730387 
 H     1.949807    -0.872202     1.694368 
 H    -0.499105     0.915670     1.875721 
 H     3.194977     1.269332     2.082099 
 H     1.663758     2.143466     2.124675 
 H     2.790021     0.510696    -0.212797 
 H     0.873078     1.239538    -1.562308 
 H     0.209579     2.142379    -0.208881 
 H     0.473813    -0.916936    -0.373154 
 H    -1.021487     0.013657    -0.393191 
 H     2.341324     3.536944     0.024243 
 H     2.964005     2.695147    -1.401909 
 H     3.909396     2.720321     0.093801 
 H     3.401469    -2.616775     4.323786 
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 تصميم ادوية مساعدة مبتكرة من حمض امينوكابروك باستخدام الطرق الحسابية
 
 
 اعداد : نداء مازن سالم لقيانية
 
 اشراف : البروفسور رفيق قرمان
 
 
  :الملخص
تصميم ادوات كيميائية فعالة لها القابلية ان تستخدم أدى توضيح الية عمل عدد من نماذج الانزيم إلى 
    كروابط لتصميم ادوية مساعدة .هذه الروابط ترتبط مع الدواء الام برابطة تساهمية لتكوين
الدواء النشط عن طريق روابط داخل الجزيء ) الى   )gurdorpيتحول  بحيث.  
) الى الدواء النشط بطريقة  gurdorp(  وتكون عملية التحول من نفسه دون أي تدخل من الإنزيمات.
مبرمجة. على سبيل المثال توضيح الية انتقال البوتونات في نموذج انزيم العالم كاربي ادى الى 
  loloneta, rivolcyca ,dica cimxnartمثل  ( gurdorp  )تصميم عدد من
 
لفة لعملية نقل البروتون ضمن جزئي من نموذج على مستويات مخت  TFDباستخدام الطرق الحسابية
حيث  ثم استغلال هذا النموذج  للعالم كاربي لتصميم خمسة ادوية مساعدة من   الانزيم للعالم كاربي
  dica ciorpaconimA-6
 
              من  gurdorPوخمسة   7-1لعملية نقل البروتون ل  TFDاستنادا الى الطرق الحسابية  
وليس هناك  niartsتبين ان سرعة انتقال البروتونات تعتمد على قوة   dica ciorpaconima-6
علاقة بين سرعة الانتقال والمسافة بين المركزين اللذين يحدث بينهما انتقال البروتونات وزاوية 
 الهجوم
للرابط وبالتالي فان سرعة  تحويل الدواء المساعد الى الدواء النشط تعتمد على الخواص الشكلية 
 المستخدم                                                                                                               .
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 عمادة الدراسات العليا
 جامعة القدس
 
 
 
 
تصميم أدوية مساعدة مبتكرة من حمض امينو كابروك بالطرق 
 الحسابية
 
 إعداد
  لقيانيةنداء مازن سالم 
 
 رسالة ماجستير
 
  القدس -فلسطين 
 
 7102/8341
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تصميم أدوية مساعدة مبتكرة من حمض امينو كابروك بالطرق 
 الحسابية
 
 
 إعداد
  لقيانيةنداء مازن سالم 
  فلسطين، جامعة القدس-ريوس صيدلةوبكال
 
 
  بروفيسور رفيق قرمانالمشرف الرئيسي: 
 
 
العلوم قدمت هذه الأطروحة استكمالا لمتطلبات درجة الماجستير في 
  فلسطين.-من كلية الدراسات العليا جامعة القدس الصيدلانية
 
 
 
 7102/8341
